Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity
Local anesthetics (LAs), such as lidocaine and mexiletine, inhibit bronchoconstriction in asthmatics, but adverse effects limit their use for this specific clinical application. In this study, we describe the anti-spasmodic properties of the mexiletine analog 2-(2-aminopropoxy)-3,5-dimethyl, 4-Br-be...
Main Authors: | Katharinne Ingrid Moraes Carvalho, Diego de Sá Coutinho, Humberto Cavalcante Joca, Artur Santos Miranda, Jader dos Santos Cruz, Emerson Teixeira Silva, Marcus Vinícius Nora Souza, Robson Xavier Faria, Patricia Machado Rodrigues e Silva, Jorge Carlos Santos Costa, Marco Aurélio Martins |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01159/full |
Similar Items
-
Molecular insights into the local anesthetic receptor within voltage-gated sodium channels using hydroxylated analogues of mexiletine
by: Jean-François eDesaphy, et al.
Published: (2012-02-01) -
Molecular Modeling of Cardiac Sodium Channel with Mexiletine
by: Boris S. Zhorov
Published: (2022-12-01) -
Anesthetic complications in a rehabilitation hospital: is the incidence related to the pre-anesthetic visit?
by: Ulises Prieto y Schwartzman, et al. -
Attenuation of intestinal ischemia-reperfusion-injury by anesthetics: a potentially protective effect of anesthetic management in experimental studies
by: Zhan Huang, et al.
Published: (2024-02-01) -
Editorial: Impact of anesthetics on cancer behavior and outcome
by: Jui-An Lin, et al.
Published: (2022-08-01)